Gilead Sciences (GILD) Stock: 7 Things to Know Before the Market Opens on December 8, 2025
Gilead Sciences (NASDAQ: GILD) heads into Monday’s session riding an event‑packed weekend: new cancer data at the ASH 2025 hematology meeting, fresh institutional‑ownership filings, and another round of valuation work from analysts and quant platforms. Here’s what investors should know about Gilead Sciences stock before the U.S. market opens on Monday, December 8, 2025. 1. Price action: defensive biotech near the top of its range As of the close on Friday, December 5, Gilead Sciences stock finished at $121.22, about 1.14% lower on the day; after‑hours trading nudged it slightly higher to ~$121.34. TechStock² At that level: Several recent analyses